Daily Archives: September 12, 2011

Civil society orgs want more done on Xpert rapid TB test pricing in South Africa

By on .

Civil society groups remain unhappy with the price South Africa is paying for the GeneXpert MTB/RIF – a rapid diagnostic for tuberculosis (TB), multidrug-resistant TB (MDR-TB) and TB in HIV-infected individuals developed by molecular diagnostics company Cepheid. Representatives from the Treatment Action Campaign (TAC), The Treatment Action Group, The AIDS Rights Alliance of South Africa and Partners in Health called on Cepheid CEO John Bishop and Dr. Giorgio Roscigno of the Foundation for Innovative New Diagnostics (FIND) – the company that co-developed Xpert with Cepheid – to do more to make the test affordable in South Africa and to shed some light on the pricing and price negotiation process…